JESSICA AXMEAR: Open Payments
NPI 1740857887 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$87 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $139 · 2025 $87
Food & beverage: $87
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
Products named: REXULTI, Qelbree, Auvelity, VRAYLAR.
Industry payments across MO — which companies pay providers there.
